We are live on ! Find out more
GCM

Gibraltar Capital Management Portfolio holdings

AUM $650M
1-Year Est. Return 24.75%
This Fund
S&P 500
This Quarter Est. Return
+12.62%
1 Year Est. Return
+24.75%
3 Year Est. Return
+56.62%
5 Year Est. Return
+81.97%
10 Year Est. Return
+386.58%
AUM
$108M
AUM Growth
+$21M
Cap. Flow
+$10.6M
Cap. Flow %
9.9%
Top 10 Hldgs %
53.22%
Holding
33
New
6
Increased
6
Reduced
16
Closed
2

Top Buys

Rank Stock Value
1
APA icon
APA Corp
APA
+$4.24M
2
CELG
Celgene Corp
CELG
+$3.33M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$3.18M
4
COL
Rockwell Collins
COL
+$2.64M
5
AGN
Allergan plc
AGN
+$2.06M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.17M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.8M
3
HP icon
Helmerich & Payne
HP
+$233K
4
BNY
Bank of New York Mellon
BNY
+$197K
5
SCHW
Charles Schwab
SCHW
+$192K

Sector Composition

Rank Sector Weight
1 Technology 27.55%
2 Financials 22.39%
3 Healthcare 14.94%
4 Industrials 13.95%
5 Communication Services 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
26
Berkshire Hathaway Class A
BRK.A
$1.1T
$976K 0.91%
4
– –
SHY icon
27
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$760K 0.71%
+8,996
New +$762K
HBAN icon
28
Huntington Bancshares
HBAN
$34.4B
$336K 0.31%
25,448
– –
CBSH icon
29
Commerce Bancshares
CBSH
$8.53B
$239K 0.22%
+6,413
New +$216K
CHK
30
DELISTED
Chesapeake Energy Corporation
CHK
$154K 0.14%
110
-11
-9% -$14.4K
AAU
31
DELISTED
Almaden Minerals Ltd
AAU
$13K 0.01%
13,500
– –
GILD icon
32
Gilead Sciences
GILD
$162B
– –
-52,640
Closed -$4.17M
TEVA icon
33
Teva Pharmaceuticals
TEVA
$40.8B
– –
-60,829
Closed -$2.8M
1
2

Similar funds

SCM
Stevens Capital Management Radnor, Pennsylvania $649M AUM 27.37% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return

Gibraltar Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Gibraltar Capital Management held 33 positions worth $108M, up 24% from $86.5M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Gibraltar Capital Management deployed $10.6M of net new capital in Q4 2016, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Celgene Corp: 29,935 shares worth $3.46M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Helmerich & Payne, an estimated $233K trimmed.

  • Gibraltar Capital Management's largest Q4 2016 buy was Celgene Corp: 29,935 shares worth $3.46M.
  • Gibraltar Capital Management added most to APA Corp in Q4 2016, an estimated $4.24M increase.
  • Gibraltar Capital Management's biggest Q4 2016 reduction was Helmerich & Payne, cutting an estimated $233K.
  • Gibraltar Capital Management fully exited Gilead Sciences in Q4 2016, selling an estimated $4.17M.
  • Gibraltar Capital Management's ten largest holdings make up 53% of its $108M portfolio in Q4 2016.
  • Gibraltar Capital Management opened 6 new positions and closed 2 in Q4 2016.
  • Gibraltar Capital Management's portfolio value rose 24% quarter-over-quarter to $108M.

Based on Gibraltar Capital Management's 13F filing for Q4 2016, filed 18 Jan 2017.